Anavex issued new U.S. patent on ANAVEX2-73
Life Sciences announced it was issued a new U.S. Patent No. 12,180,174 entitled “A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF ...
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of ...
Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...